Form 4: InspireMD Director Michael Berman Acquires Shares and Warrants

Director Michael Berman reports acquisition of InspireMD shares and warrants, along with indirect holdings through a revocable trust.

Summary

• On June 24, 2024, Michael Berman, a director of InspireMD, Inc. (NSPR), acquired 61,249 shares of common stock at a price of $1.3827 per share.
• The transaction also involved the acquisition of Series H warrants, exercisable at $1.3827, for 61,249 shares of common stock.
• Following the reported transactions, Berman directly owns 232,042 shares of common stock.
• Berman also indirectly owns 183,746 shares through the Michael Berman Revocable Trust.
• No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The acquisition of shares by a director could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• Director's acquisition of shares and warrants may signal confidence in the company's future prospects.

Management Comments

• No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the actions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director may influence investor sentiment.

Key Dates